Sapient Capital LLC Purchases 15,620 Shares of Colgate-Palmolive Company $CL

Sapient Capital LLC lifted its position in Colgate-Palmolive Company (NYSE:CL) by 240.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,129 shares of the company’s stock after purchasing an additional 15,620 shares during the quarter. Sapient Capital LLC’s holdings in Colgate-Palmolive were worth $1,888,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Corient Private Wealth LP raised its holdings in shares of Colgate-Palmolive by 29.0% during the second quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock worth $58,639,000 after purchasing an additional 143,812 shares during the last quarter. Brandywine Financial Group boosted its holdings in Colgate-Palmolive by 35,612.3% in the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after purchasing an additional 72,649 shares during the last quarter. Bank of America Corp DE purchased a new stake in Colgate-Palmolive in the second quarter valued at $567,483,000. SEB Asset Management AB acquired a new stake in Colgate-Palmolive during the 1st quarter worth about $91,149,000. Finally, Robinhood Asset Management LLC purchased a new position in shares of Colgate-Palmolive during the 2nd quarter valued at about $11,554,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

CL has been the subject of several analyst reports. Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Piper Sandler reduced their price target on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, September 21st. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Barclays raised their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Monday, August 3rd. Twelve analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $98.65.

Colgate-Palmolive Price Performance

NYSE CL traded up $0.86 on Thursday, hitting $88.07. The company had a trading volume of 4,080,637 shares, compared to its average volume of 5,703,748. The company has a market capitalization of $70.21 billion, a PE ratio of 34.95, a PEG ratio of 4.07 and a beta of 0.33. The company’s fifty day moving average price is $89.16 and its 200-day moving average price is $88.77. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. The business had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.92 earnings per share. As a group, analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is 84.13%.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director John Cahill sold 4,170 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Noel Wallace sold 161,021 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 175,191 shares of company stock valued at $16,110,903 over the last quarter. 0.43% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.